(Q45059328)

9 December 2017

title

Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415. (English)

1 reference

9 December 2017

0 references

4

1 reference

9 December 2017

Jeanne Stemmelin

1

1 reference

9 December 2017

Ludovit Lukovic

series ordinal

2

1 reference

9 December 2017

Nicolas Salome

series ordinal

3

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

9 December 2017

published in

Neuropsychopharmacology

1 reference

9 December 2017

volume

30

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

35-42

1 reference

Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

An early lesion of the lateral septal nuclei produces changes in the forced swim test depending on gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Septal vasopressin modulates social memory in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Vasopressin released within the septal brain area during swim stress modulates the behavioural stress response in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Forced swimming triggers vasopressin release within the amygdala to modulate stress-coping strategies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Participation of the lateral septal nuclei (LSN) in the antidepressant-like actions of progesterone in the forced swimming test (FST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Differential lateral septal vasopressin in wild-type rats: correlation with aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Pancreatic vasopressin V1breceptors: characterization in In-R1-G9 cells and localization in human pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Role of the amygdala and periaqueductal gray in anxiety and panic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

The vasopressin V1b receptor as a therapeutic target in stress-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

The vasopressin receptors colocalize with vasopressin in the magnocellular neurons of the rat supraoptic nucleus and are modulated by water balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Extrapituitary expression of the rat V1b vasopressin receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Depression: a new animal model sensitive to antidepressant treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Regulation of Pituitary V1b Vasopressin Receptor Messenger Ribonucleic Acid by Adrenalectomy and Glucocorticoid Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Septal lesions inhibit fear reactions in two animal models of anxiolytic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

The role of the lateral septum in anxiolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

Vasopressin cells in the medial amygdala of the rat project to the lateral septum and ventral hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

inferred from DOI database lookup

7 January 2021

based on heuristic

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

inferred from DOI database lookup

7 January 2021

based on heuristic

A simple and reliable conflict procedure for testing anti-anxiety agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300562

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.NPP.1300562

1 reference

Dimensions Publication ID

9 December 2017

1019749514

0 references

1 reference